
Nordson (NDSN) Stock Forecast & Price Target
Nordson (NDSN) Analyst Ratings
Bulls say
Nordson has demonstrated a strong outlook for fiscal 2023 with approximately $2.6 billion in revenue, underpinned by organic growth within its medical interventional solutions and increasing demand in industrial coatings and semiconductor-related markets. The anticipated moderate recovery in key end markets, particularly driven by planned customer investments and favorable macroeconomic trends, supports a forecasted organic sales growth at a firm mid-single-digit rate. Additionally, the company benefits from a healthy backlog, strong free cash flow generation, and a solid balance sheet, positioning it well for continued growth and potential shareholder returns through M&A or share repurchases.
Bears say
Nordson anticipates F2Q24 sales to range between $645 million and $670 million, which reflects a downward revision from previous estimates mainly due to persistent weakness in the electronics end market and an estimated $10 million to $15 million negative impact from the Chinese New Year. The company's guidance has been narrowed based on current order entry trends and declining backlog visibility, with a noted decrease in backlog levels from approximately $800 million in F4Q23 to around $750 million by the end of F1Q24. Additionally, Nordson's Advanced Technology Solutions segment has consistently underperformed sales and margin projections for four consecutive quarters, raising concerns about potential downside risks to FY24 financial metrics if a recovery fails to materialize.
This aggregate rating is based on analysts' research of Nordson and is not a guaranteed prediction by Public.com or investment advice.
Nordson (NDSN) Analyst Forecast & Price Prediction
Start investing in Nordson (NDSN)
Order type
Buy in
Order amount
Est. shares
0 shares